ARCHIVES

In Brief: FDA’s Tabor To Head Biological Carcinogenesis in DCE; Steve Larson to Leave NIH for Memorial

This article is from The Cancer Letter archive.

Vol. 14 No. 18 | April 29, 1988

Download PDF Visit The Full Archive

Related Articles

NCI Unconventional Innovations Program releases Broad Agency Announcement.

October 24, 2003

In Brief: Breast Cancer Detection Concept Was For Grants, Not Contracts; Wallens Gets Five Years Probation

November 16, 1984

NCI-Approved Clinical Trials

September 29, 2006

Foreign awards Less Than 1% Of NCI Budget

June 22, 1990

Organ Site Report On Pancreas Project, Breast cancer TF

May 7, 1976

Onward to 2010? NCI promises faster progress for more money.

May 20, 2005